« Back
Home /
Verinurad

Verinurad

Item no.	TMO-T3994-10mM
Manufacturer	TargetMol
CASRN	1352792-74-5
Amount	1 mL x 10 mM (in DMSO)
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 2 mg 50 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Citations	1. Diaz-Torne C, Perez-Herrero N, Perez-Ruiz F. New medications in development for the treatment of hyperuricemia of gout. Curr Opin Rheumatol. 2015 Mar;27(2):164-9.
Smiles	CC(C)(Sc1ccncc1-c1ccc(C#N)c2ccccc12)C(O)=O
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	RDEA3170
Shipping Condition	Cool pack
Available
Manufacturer - Targets	OAT
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	348.42
Description	Verinurad (RDEA3170) (RDEA3170) is an organic anion transporter URAT1 (SLC22A12) inhibitor for the treatment of gout and hyperuricemia.
Pathways	Membrane transporter/Ion channel
Bioactivity	Verinurad, also known as RDEA3170, is an organic anion transporter URAT1 (SLC22A12) inhibitor, is being developed by Ardea Biosciences (a subsidiary of AstraZeneca) for the treatment of gout and hyperuricaemia.
Receptor	URAT1

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T3994-10mM-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mL x 10 mM (in DMSO)

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question